New Sydney cancer research centre looks into metabolic causes of cancer Posted on March 31, 2016February 25, 2018 by Carly du Toit The Centenary Institute, in partnership with the Australian Cancer Research Foundation (ACRF) and Sydney Catalyst, today opened the new ACRF Centenary Cancer Research Centre at the University of Sydney’s Charles Perkins Centre in Camperdown. The new centre will focus on two key specialist areas of cancer research – understanding the inflammatory and metabolic causes of cancer and the drivers behind cancer-driven blood clotting. By investigating these two areas, the research team hopes to unveil how changes in metabolism support cancer growth and how these changes can be controlled by new treatments and therapies. The ACRF Centenary Cancer Research Centre will be headed by Professor Philip Hogg, a world-renowned researcher whose expertise lies in the discovery of new cancer-active drugs and therapies. The centre will host a team of over 40 dedicated cancer researchers whose capability spans fundamental research to clinical trials. “I would like to thank ACRF and their supporters for funding the new centre. It will significantly expand the Centenary Institute’s capabilities in cancer research and accelerate the development of new treatments for cancer patients,” said Professor Hogg. “Having this new facility has also helped us attract a brilliant team that includes some of the world’s leading scientific minds.” ACRF’s CEO, Dr Ian Brown said, “Supporters of ACRF helped lay the foundation for this centre, a centre that will help the team at Centenary reveal key information that will help inform better cancer treatments which is an exciting step forward.” The new centre is located within the University of Sydney’s Charles Perkins Centre and is the first dedicated cancer research centre in the Royal Prince Alfred (RPA) Hospital and The University of Sydney Precinct. The establishment has been a collaborative effort lead by the Centenary Institute and included the Australian Cancer Research Foundation, Sydney Catalyst, Sydney University, the Charles Perkins Centre, RPA Hospital and Chris O’Brien Lifehouse. Image from left: ACRF Chairman Mr Tom S Dery AO, NSW Minister for Medical Research, The Hon. Pru Goward, MP, Centre Director Professor Philip Hogg and Executive Director Mathew Vadas AO.
Top cancer award to ACRF research expert Posted on May 9, 2009February 25, 2018 by Carly du Toit Congratulations Professor Philip Hogg, a member of the Foundation’s prestigious Medical Research Advisory Committee, who has been awarded this year’s top cancer science award. At a black-tie dinner in Sydney on the 21st of May, the Commonwealth’s Chief Medical Officer, Professor Jim Bishop, AO, presented Prof Hogg with the NSW Premier’s Award for Outstanding Cancer Researcher. Professor Hogg received a $50,000 cheque honouring his breakthrough scientific achievements. Professor Hogg, director of the University of NSW Cancer Research Centre, developed a dye that fastens onto dead or dying cancer cells and reveals whether cancer treatments are working just days into the course. He also discovered a protein that stops cancerous tumours growing by targeting blood cell production, helping to extend the lives of cancer patients. Continue reading “Top cancer award to ACRF research expert”
